Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Michael James PhD

Michael James PhD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Surgery
Division: Administration
Program: General

Member of the Cancer Center

MCW Program / Core Facilities

  • Tumor Progression and Metastasis Program Member
  • Publications (27)

  • Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4. (Xiao F, Zhang P, Wang Y, Tian Y, James M, Huang CC, Wang L, Wang L) Mol Carcinog 2020 Jan;59(1):45-55 PMID: 31659808 SCOPUS ID: 2-s2.0-85074694919 10/30/2019    
  • CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells. (Clarke WR, Amundadottir L, James MA) Int J Cancer 2019 03 15;144(6):1367-1378 PMID: 30468251 SCOPUS ID: 2-s2.0-85059544138 11/24/2018    
  • Stromal inflammation in pancreatic cancer: Mechanisms and translational applications (Boyle KA, James MA, Tsai S, Evans DB, Dwinell MB) Pancreatic Cancer 11 April 2018:481-508 SCOPUS ID: 2-s2.0-85054043119 04/11/2018    
  • Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models. (Tsai S, McOlash L, Palen K, Johnson B, Duris C, Yang Q, Dwinell MB, Hunt B, Evans DB, Gershan J, James MA) BMC Cancer 2018 03 27;18(1):335 PMID: 29587663 PMCID: PMC5870823 SCOPUS ID: 2-s2.0-85044523365 03/29/2018       23 Citations
  • Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell Lines. (Bodle CR, Mackie DI, Hayes MP, Schamp JH, Miller MR, Henry MD, Doorn JA, Houtman JCD, James MA, Roman DL) J Nat Prod 2017 07 28;80(7):1992-2000 PMID: 28621943 PMCID: PMC5567870 SCOPUS ID: 2-s2.0-85026545039 06/18/2017       8 Citations
  • Stromal Inflammation in Pancreatic Cancer: Mechanisms and Translational Applications (Boyle K, James MA, Tsai S, Evans DB, Dwinell MB.) Pancreatic Cancer. 2nd Ed. Springer-Verlag New York DOI: 10.1007/978-1-4939-6631-8_55-1 01/01/2017    
  • Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling. (Puskás LG, Mán I, Szebeni G, Tiszlavicz L, Tsai S, James MA) Mol Cancer Ther 2016 05;15(5):985-97 PMID: 26939707 PMCID: PMC4873426 SCOPUS ID: 2-s2.0-84969522621 03/05/2016       6 Citations
  • Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells. (Lee Y, Wang Y, James M, Jeong JH, You M) Mol Carcinog 2016 May;55(5):991-1001 PMID: 26052929 PMCID: PMC6003619 SCOPUS ID: 2-s2.0-84930532549 06/09/2015       24 Citations
  • Functional characterization of RAD52 as a lung cancer susceptibility gene in the 12p13.33 locus. (Lieberman R, Xiong D, James M, Han Y, Amos CI, Wang L, You M) Mol Carcinog 2016 May;55(5):953-63 PMID: 26013599 PMCID: PMC4662629 SCOPUS ID: 2-s2.0-84930260740 05/28/2015       16 Citations
  • A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression. (James MA, Seibel WL, Kupert E, Hu XX, Potharla VY, Anderson MW) Anticancer Drugs 2015 Jun;26(5):518-30 PMID: 25646742 SCOPUS ID: 2-s2.0-84939967936 02/04/2015       2 Citations
  • CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis. (James MA, Vikis HG, Tate E, Rymaszewski AL, You M) Cancer Res 2014 Feb 15;74(4):1116-27 PMID: 24366883 PMCID: PMC6005686 SCOPUS ID: 2-s2.0-84894226710 12/25/2013       35 Citations
  • Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus. (James MA, Wen W, Wang Y, Byers LA, Heymach JV, Coombes KR, Girard L, Minna J, You M) PLoS One 2012;7(6):e36116 PMID: 22675468 PMCID: PMC3366984 SCOPUS ID: 2-s2.0-84861899749 06/08/2012       65 Citations
  • Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. (Liu P, Morrison C, Wang L, Xiong D, Vedell P, Cui P, Hua X, Ding F, Lu Y, James M, Ebben JD, Xu H, Adjei AA, Head K, Andrae JW, Tschannen MR, Jacob H, Pan J, Zhang Q, Van den Bergh F, Xiao H, Lo KC, Patel J, Richmond T, Watt MA, Albert T, Selzer R, Anderson M, Wang J, Wang Y, Starnes S, Yang P, You M) Carcinogenesis 2012 Jul;33(7):1270-6 PMID: 22510280 PMCID: PMC3499051 SCOPUS ID: 2-s2.0-84865168855 04/19/2012       121 Citations
  • Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer. (Lu Y, Liu P, Van den Bergh F, Zellmer V, James M, Wen W, Grubbs CJ, Lubet RA, You M) Cancer Prev Res (Phila) 2012 Feb;5(2):248-59 PMID: 21982874 SCOPUS ID: 2-s2.0-84863237623 10/11/2011       13 Citations
  • Principles for the post-GWAS functional characterization of cancer risk loci. (Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, You M, Mills IG) Nat Genet 2011 Jun;43(6):513-8 PMID: 21614091 PMCID: PMC3325768 SCOPUS ID: 2-s2.0-79957604678 05/27/2011       268 Citations
  • Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis. (James MA, Fu H, Liu Y, Chen DR, You M) Mol Carcinog 2011 Jan;50(1):1-7 PMID: 21061266 PMCID: PMC6004604 SCOPUS ID: 2-s2.0-78650185177 11/10/2010       40 Citations
  • Chemopreventive effects of pioglitazone on chemically induced lung carcinogenesis in mice. (Wang Y, James M, Wen W, Lu Y, Szabo E, Lubet RA, You M) Mol Cancer Ther 2010 Nov;9(11):3074-82 PMID: 21045137 SCOPUS ID: 2-s2.0-78649668811 11/04/2010       40 Citations
  • Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor. (Lu Y, Liu P, James M, Vikis HG, Liu H, Wen W, Franklin A, You M) Oncogene 2010 Feb 18;29(7):1041-9 PMID: 19915612 PMCID: PMC6019621 SCOPUS ID: 2-s2.0-77149169733 11/17/2009       15 Citations
  • Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1. (Liu Y, Liu P, Wen W, James MA, Wang Y, Bailey-Wilson JE, Amos CI, Pinney SM, Yang P, de Andrade M, Petersen GM, Wiest JS, Fain PR, Schwartz AG, Gazdar A, Gaba C, Rothschild H, Mandal D, Kupert E, Lee J, Seminara D, Minna J, Anderson MW, You M) Cancer Res 2009 Oct 01;69(19):7844-50 PMID: 19789337 PMCID: PMC2846106 SCOPUS ID: 2-s2.0-70350215708 10/01/2009       37 Citations
  • Identification of Las2, a major modifier gene affecting the Pas1 mouse lung tumor susceptibility locus. (Liu PY, Vikis H, James M, Lu Y, Wang DL, Liu HB, Wen WD, Wang Y, You M) Cancer Res 2009 Aug 01;69(15):6290-8 PMID: 19622765 SCOPUS ID: 2-s2.0-68049120471 07/23/2009       6 Citations
  • Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. (You M, Wang D, Liu P, Vikis H, James M, Lu Y, Wang Y, Wang M, Chen Q, Jia D, Liu Y, Wen W, Yang P, Sun Z, Pinney SM, Zheng W, Shu XO, Long J, Gao YT, Xiang YB, Chow WH, Rothman N, Petersen GM, de Andrade M, Wu Y, Cunningham JM, Wiest JS, Fain PR, Schwartz AG, Girard L, Gazdar A, Gaba C, Rothschild H, Mandal D, Coons T, Lee J, Kupert E, Seminara D, Minna J, Bailey-Wilson JE, Amos CI, Anderson MW) Clin Cancer Res 2009 Apr 15;15(8):2666-74 PMID: 19351763 PMCID: PMC2746091 SCOPUS ID: 2-s2.0-65249131768 04/09/2009       59 Citations
  • RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway. (James MA, Lu Y, Liu Y, Vikis HG, You M) Cancer Res 2009 Mar 01;69(5):2108-16 PMID: 19244110 PMCID: PMC2746047 SCOPUS ID: 2-s2.0-62449130006 02/27/2009       61 Citations
  • Common human cancer genes discovered by integrated gene-expression analysis. (Lu Y, Yi Y, Liu P, Wen W, James M, Wang D, You M) PLoS One 2007 Nov 07;2(11):e1149 PMID: 17989776 PMCID: PMC2065803 SCOPUS ID: 2-s2.0-41149106140 11/09/2007       59 Citations
  • EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. (Vikis H, Sato M, James M, Wang D, Wang Y, Wang M, Jia D, Liu Y, Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Yang P, Wiest JS, Fain PR, Schwartz AG, Gazdar A, Gaba C, Rothschild H, Mandal D, Kupert E, Seminara D, Viswanathan A, Govindan R, Minna J, Anderson MW, You M) Cancer Res 2007 May 15;67(10):4665-70 PMID: 17510392 PMCID: PMC3460269 SCOPUS ID: 2-s2.0-34250329445 05/19/2007       74 Citations
  • HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300. (James MA, Lee JH, Klingelhutz AJ) Int J Cancer 2006 Oct 15;119(8):1878-85 PMID: 16708385 PMCID: PMC2223064 05/19/2006       55 Citations
  • Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. (James MA, Lee JH, Klingelhutz AJ) J Virol 2006 Jun;80(11):5301-7 PMID: 16699010 PMCID: PMC1472131 05/16/2006       105 Citations
  • Reduction of fecal shedding and egg contamination of Salmonella enteritidis by increasing the number of heterophil adaptations. (Kramer TT, Reinke CR, James M) Avian Dis 1998 Jul-Sep;42(3):585-8 PMID: 9777160 10/20/1998       7 Citations
  • Last update: 12/13/2019
    jenkins-FCD Prod-444 eb4ebd1a08581aba961d3befd3b851a3c3ec6b46